Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ARDELYX, INC. | 57,291 | reported | 18 Jun 2025 | tx 3+121,748 |
| Sagimet Biosciences Inc. | 51,459 | reported | 05 Jun 2024 | tx 15+116,887−388,620 |
| GILEAD SCIENCES, INC. | 36,753 | reported | 10 Dec 2024 | tx 106+1,159,960−590,969 |
| ArriVent BioPharma, Inc. | 15,502 | reported | 18 Jun 2025 | tx 2+43,848 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 Jun 2025 | GRANT_AWARD | ARDELYX, INC. | 15,235 | 0.00 USD | |
| 18 Jun 2025 | GRANT_AWARD | ArriVent BioPharma, Inc. | 15,502 | 0.00 USD | deriv |
| 28 Apr 2025 | GRANT_AWARD | ARDELYX, INC. | 42,056 | 0.00 USD | |
| 28 Apr 2025 | GRANT_AWARD | ARDELYX, INC. | 64,457 | 0.00 USD | deriv |
| 28 Apr 2025 | GRANT_AWARD | ArriVent BioPharma, Inc. | 28,346 | 0.00 USD | deriv |
| 10 Dec 2024 | TAX_WITHHOLDING | GILEAD SCIENCES, INC. | 1,771 | 92.34 USD | |
| 10 Dec 2024 | EXERCISE | GILEAD SCIENCES, INC. | 3,820 | — | |
| 10 Dec 2024 | EXERCISE | GILEAD SCIENCES, INC. | 3,820 | — | deriv |
| 27 Nov 2024 | SALE | GILEAD SCIENCES, INC. | 57,294 | 91.79 USD | |
| 27 Nov 2024 | EXERCISE | GILEAD SCIENCES, INC. | 88,119 | 65.38 USD | |
| 27 Nov 2024 | SALE | GILEAD SCIENCES, INC. | 10,399 | 92.00 USD | |
| 27 Nov 2024 | SALE | GILEAD SCIENCES, INC. | 3,199 | 91.80 USD | |
| 27 Nov 2024 | SALE | GILEAD SCIENCES, INC. | 5,200 | 91.80 USD | |
| 27 Nov 2024 | SALE | GILEAD SCIENCES, INC. | 88,119 | 92.00 USD | |
| 27 Nov 2024 | EXERCISE | GILEAD SCIENCES, INC. | 57,294 | 57.92 USD | |
| 27 Nov 2024 | EXERCISE | GILEAD SCIENCES, INC. | 57,294 | 0.00 USD | deriv |
| 27 Nov 2024 | EXERCISE | GILEAD SCIENCES, INC. | 88,119 | 0.00 USD | deriv |
| 06 Nov 2024 | SALE | GILEAD SCIENCES, INC. | 20,590 | 91.50 USD | |
| 06 Nov 2024 | SALE | GILEAD SCIENCES, INC. | 5,000 | 91.50 USD | |
| 06 Nov 2024 | EXERCISE | GILEAD SCIENCES, INC. | 25,000 | 57.92 USD | |
| 06 Nov 2024 | EXERCISE | GILEAD SCIENCES, INC. | 25,000 | 0.00 USD | deriv |
| 01 Oct 2024 | SALE | GILEAD SCIENCES, INC. | 2,000 | 83.83 USD | |
| 12 Sept 2024 | SALE | GILEAD SCIENCES, INC. | 21,246 | 84.50 USD | |
| 12 Sept 2024 | EXERCISE | GILEAD SCIENCES, INC. | 25,000 | 57.92 USD | |
| 12 Sept 2024 | EXERCISE | GILEAD SCIENCES, INC. | 25,000 | 0.00 USD | deriv |